Tilaknagar Industries Ltd. (TI.NS)
INR 414.6
(1.64%)
INR 414.6
(1.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 978.56 Million | 712.89 Million | 651.05 Million | 854.65 Million | 1.9 Billion | 907.73 Million |
| Net Income | 1.38 Billion | 1.49 Billion | 411.92 Million | -385.78 Million | 2.71 Billion | -1.59 Billion |
| Depreciation & Amortization | 318.93 Million | 323.46 Million | 327.42 Million | 331.24 Million | 329.81 Million | 367.49 Million |
| Deferred income taxes | - | -284.59 Million | 90.23 Million | - | 1.41 Billion | 559.22 Million |
| Stock-based compensation | 55.72 Million | 34.95 Million | 36.49 Million | - | 2.56 Million | 20.16 Million |
| Change in working capital | -744.5 Million | -727.85 Million | -676.44 Million | 142.89 Million | 939.22 Million | -259.79 Million |
| Other non-cash items | 1.49 Billion | -132 Million | 461.43 Million | 766.31 Million | -3.49 Billion | 1.81 Billion |
| Investing Cash Flow | -182.89 Million | -117.68 Million | -258.87 Million | -3.21 Million | 46.38 Million | -31.32 Million |
| Investments in PPE | -82.18 Million | -108.78 Million | -33.49 Million | -841 Thousand | -4.74 Million | -24.92 Million |
| Acquisitions | -102.49 Million | -5 Million | 264.15 Million | 406 Thousand | 445 Thousand | 16.78 Million |
| Investment purchases | -1.27 Billion | -849.95 Million | -946.36 Million | -8.67 Million | -445 Thousand | -1.06 Billion |
| Sales/Maturities of investments | 1.17 Billion | 640 Million | 703.21 Million | 8.26 Million | 38.49 Million | 1.05 Billion |
| Other Investing Activities | 242 Thousand | 206.06 Million | -246.39 Million | -2.36 Million | 12.62 Million | -13.72 Million |
| Financing Cash Flow | -1.04 Billion | -674.46 Million | -413.41 Million | -776.16 Million | -2.08 Billion | -1.04 Billion |
| Debt repayment | -1.3 Billion | -2.49 Billion | -1.5 Billion | -559.47 Million | -460.6 Million | -65.62 Million |
| Dividends payments | -48.24 Million | -16.09 Million | -1.18 Million | -1.03 Million | -642 Thousand | - |
| Common Stock Repurchased | - | 512.5 Million | 585.84 Million | 555.44 Million | - | - |
| Common Stock Issuance | 323.81 Million | 1.98 Billion | 921.9 Million | 4.02 Million | - | 4.9 Million |
| Other Financing Activities | 77.05 Million | -658.37 Million | -412.23 Million | -775.12 Million | -1.62 Billion | -982.36 Million |
| Accounts receivables | -843.19 Million | -1.05 Billion | -532.38 Million | 585.12 Million | -28.01 Million | -748.63 Million |
| Accounts payables | -145.89 Million | 609.62 Million | -508.93 Million | -128.8 Million | 794.32 Million | 768.32 Million |
| Inventory | 153.76 Million | -443.59 Million | -32.08 Million | -218.19 Million | 376.99 Million | -179.88 Million |
| Other working capital | 90.82 Million | 162.92 Million | 396.95 Million | -95.23 Million | -204.08 Million | -99.6 Million |
| Cash at beginning of period | 348.36 Million | 427.4 Million | 448.64 Million | 373.35 Million | 501.7 Million | 668.36 Million |
| Cash at end of period | 417.98 Million | 348.14 Million | 427.4 Million | 448.64 Million | 373.35 Million | 501.7 Million |
| Capital Expenditure | -82.18 Million | -108.78 Million | -33.49 Million | -841 Thousand | -4.74 Million | -24.92 Million |
| Effect of forex changes on cash | - | - | - | -1000.00 | - | - |
| Net cash flow / Change in cash | 69.62 Million | -79.25 Million | -21.23 Million | 75.28 Million | -128.34 Million | -166.66 Million |
| Free Cash Flow | 896.38 Million | 604.1 Million | 617.56 Million | 853.81 Million | 1.9 Billion | 882.8 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 400.86 Million | 1.38 Billion | 314.51 Million | 437.68 Million | 370.43 Million | 257.47 Million |
| Depreciation & Amortization | - | 318.93 Million | - | 80 Million | 82.45 Million | 78.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 55.72 Million | 55.72 Million | - | - | - |
| Change in working capital | - | -744.5 Million | - | - | - | - |
| Other non-cash items | -400.86 Million | 1.49 Billion | -370.23 Million | -437.68 Million | -370.43 Million | -257.47 Million |
| Investing Cash Flow | - | -182.89 Million | - | - | - | - |
| Investments in PPE | - | -82.18 Million | - | - | - | - |
| Acquisitions | - | -102.49 Million | - | - | - | - |
| Investment purchases | - | -1.27 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 1.17 Billion | - | - | - | - |
| Other Investing Activities | - | 242 Thousand | - | - | - | - |
| Financing Cash Flow | - | -1.04 Billion | - | - | - | - |
| Debt repayment | - | -1.3 Billion | - | - | - | - |
| Dividends payments | - | -48.24 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 323.81 Million | - | - | - | - |
| Other Financing Activities | - | 77.05 Million | - | - | - | - |
| Accounts receivables | - | -843.19 Million | - | - | - | - |
| Accounts payables | - | -145.89 Million | - | - | - | - |
| Inventory | - | 153.76 Million | - | - | - | - |
| Other working capital | - | 90.82 Million | - | - | - | - |
| Cash at beginning of period | - | 348.36 Million | - | 400.69 Million | 235.78 Million | 348.36 Million |
| Cash at end of period | - | 417.98 Million | - | 560.7 Million | 400.69 Million | 504.48 Million |
| Capital Expenditure | - | -82.18 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 69.62 Million | - | 160.01 Million | 164.91 Million | 156.11 Million |
| Free Cash Flow | - | 896.38 Million | - | 160.01 Million | 164.91 Million | 156.11 Million |
LXCHEM
RXMD
MOREPENLAB
DOM
MAXHEALTH
PHVS